Article Text
Commentary
Commentary on 'Payment in challenge studies: ethics, attitudes and a new payment for risk model'
Statistics from Altmetric.com
Footnotes
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; internally peer reviewed.
Linked Articles
Read the full text or download the PDF:
Other content recommended for you
- Payment in challenge studies: ethics, attitudes and a new payment for risk model
- Compensating for research risk: permissible but not obligatory
- Fair go: pay research participants properly or not at all
- On measuring attitudes about payment for research
- Payment in challenge studies from an economics perspective
- Controlled human infection with Neisseria lactamica in late pregnancy to measure horizontal transmission and microbiome changes in mother–neonate pairs: a single-arm interventional pilot study protocol
- Should practice and policy be revised to allow for risk-proportional payment to human challenge study participants?
- Protocol for the challenge non-typhoidal Salmonella (CHANTS) study: a first-in-human, in-patient, double-blind, randomised, safety and dose-escalation controlled human infection model in the UK
- S109 A seropositive SARS-CoV-2 controlled human infection model demonstrating potent protective immunity and identification of immune correlates of protection
- Controlled human infection with SARS-CoV-2 to study COVID-19 vaccines and treatments: bioethics in Utopia